About Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) is a rare disease catalogued by Orphanet (ORPHA:402023). It is associated with the RBM15, MRTFA genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) trials.
Search ClinicalTrials.gov for "Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)" or filter by Orphanet code ORPHA:402023 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13). Updated daily.